product
larg
quantiti
viral
vector
crucial
success
gene
therapi
clinic
need
higher
titer
herp
simplex
vector
therapeut
use
well
manufactur
clinic
grade
adenoassoci
viru
aav
vector
yield
increas
primari
human
fibroblast
treat
antiinflammatori
drug
like
dexamethason
valproic
acid
search
compound
would
increas
yield
investig
anoth
antiinflammatori
compound
aurintricarboxyl
acid
ata
although
ata
previous
shown
antivir
effect
find
low
micromolar
concentr
ata
increas
vector
product
yield
result
show
use
ata
increas
titer
import
implic
product
certain
vector
well
recombin
aav
vector
recombin
adenovirusassoci
viru
raav
vector
success
introduc
sever
human
gene
therapi
clinic
trial
nonpathogen
natur
low
toxic
minim
immunogen
longterm
persist
product
larg
quantiti
clinic
grade
raav
vector
gene
therapi
challeng
due
limit
scalabl
commonli
use
cotransfect
protocol
aav
abl
replic
first
found
propag
adenovirus
herp
virus
coinfect
cell
first
scalabl
raav
protocol
base
adenoviru
infect
raavrepcap
cell
line
besid
adenovirus
also
herpesvirus
shown
provid
complet
helper
viru
function
product
aav
virion
minim
set
herp
simplex
viru
gene
requir
aav
replic
packag
identifi
earli
gene
gene
encod
compon
core
replic
machineryth
helicas
primas
primas
accessori
protein
u
l
u
l
u
l
singlestrand
dnabind
protein
u
l
protocol
product
raav
serotyp
vector
use
amplicon
express
rep
cap
combin
helper
vector
describ
protocol
modifi
optim
sever
group
use
coinfect
two
vector
replicationdefici
infectedcel
protein
one
carri
raav
proviru
second
bear
repcap
gene
use
vector
histor
limit
rel
low
titer
raav
vector
yield
rhsvbase
manufactur
thu
would
affect
titer
helper
therefor
sever
method
improv
yield
studi
ie
chang
propag
condit
use
antiinflammatori
compound
known
inhibit
host
defens
mechan
like
dexamethason
valproic
acid
search
compound
would
increas
yield
investig
anoth
antiinflammatori
compound
aurintricarboxyl
acid
ata
ata
heterogen
mixtur
polym
accredit
continu
grow
number
biolog
activ
ata
mostli
known
antivir
agent
sever
virus
like
hiv
herpesviru
sarscov
other
howev
ata
block
replic
adenoviru
type
report
increas
adenoviru
type
titer
human
embryon
kidney
hek
cell
investig
effect
ata
vector
product
yield
vero
cell
test
stock
produc
presenc
ata
raav
manufactur
protocol
ata
effect
yield
cell
test
whether
ata
could
increas
yield
vector
cell
ata
appli
media
infect
ata
dilut
step
ata
figur
interestingli
ata
treatment
delay
plaqu
format
cell
lysi
cell
monolay
cytopath
effect
time
harvest
hour
postinfect
compar
cytopath
effect
absenc
ata
data
shown
determin
concentr
condit
ata
addit
impact
hsv
dnase
resist
particl
per
millilit
drpml
plaqueform
unit
per
millilit
pfuml
titer
ata
ad
vari
concentr
ata
either
sixwel
plate
first
step
ata
figur
flask
step
ata
ata
figur
protocol
show
hsv
yield
increas
optim
condit
would
either
ata
infect
step
ata
dilut
final
concentr
ata
ad
ata
dilut
step
ata
achiev
final
concentr
ata
figur
c
exampl
supernat
titer
drpml
pfuml
ata
protocol
drpml
pfuml
ata
protocol
compar
drpml
pfuml
untreat
control
ata
figur
result
express
mean
sd
two
independ
experi
n
import
serum
presenc
atahsv
protocol
test
effect
serumfre
media
drpml
pfuml
titer
abovedescrib
atahsv
protocol
use
fetal
bovin
serum
fb
figur
exampl
ata
protocol
serumfre
media
result
titer
reduct
drpml
pfuml
fb
drpml
fb
pfuml
titer
valu
detect
limit
figur
even
dramat
effect
serumfre
media
seen
ata
protocol
drpml
pfuml
titer
valu
detect
limit
data
shown
effect
ata
wildtyp
titer
cultur
effect
ata
drpml
viral
titer
wildtyp
wt
strain
ko
mcintyr
test
propag
vero
cell
use
ata
protocol
figur
vero
cell
oneway
analysi
varianc
tukey
multipl
comparison
test
shown
ata
significantli
increas
p
n
ko
strain
drpml
titer
drpml
drpml
ata
figur
mcintyr
viru
ata
titer
also
elev
drpml
drpml
ata
accord
analysi
varianc
differ
signific
p
n
figur
contrari
cell
mcintyr
strain
titer
significantli
increas
p
n
ata
drpml
drpml
ata
figur
titer
ko
strain
cell
hand
even
drop
drpml
drpml
ata
accord
analysi
varianc
differ
signific
p
n
figur
larger
studi
n
conduct
sixwel
plate
twoway
analysi
varianc
sidak
multipl
comparison
test
shown
ata
significantli
increas
p
n
vector
rhsvenhanc
green
fluoresc
protein
egfp
drpml
titer
cell
drpml
drpml
titer
mcintyr
strain
cell
significantli
increas
drpml
p
figur
effect
residu
ata
hsv
stock
product
raav
virion
ultim
goal
raav
product
investig
whether
presenc
ata
stock
would
influenc
raav
yield
raavgfp
vector
produc
coinfect
rhsvegfp
vector
cell
use
stock
contain
ata
stock
prepar
ata
protocol
see
materi
method
effect
residu
ata
stock
result
small
statist
signific
increas
raav
titer
drpml
p
compar
raav
drpml
titer
made
use
naiv
stock
drpml
n
shown
figur
ata
also
slightli
increas
raav
yield
drpcell
ata
spike
directli
cell
media
coinfect
step
effect
observ
ata
concentr
higher
studi
shown
first
time
micromolar
concentr
ata
increas
titer
certain
strain
variou
cell
line
raav
manufactur
protocol
yield
raav
limit
maxim
titer
helper
vector
addit
presenc
residu
ata
stock
neg
influenc
raav
yield
thu
find
import
largescal
vector
product
raav
vector
product
previous
sever
group
investig
possibl
increas
titer
chang
propag
condit
use
reagent
capabl
decreas
host
defens
known
induc
partial
evad
host
antivir
respons
dexamethason
valproic
acid
shown
increas
yield
either
inhibit
cellular
defens
viral
propag
induct
interferon
ifn
respons
antivir
gene
ata
report
reduc
induc
nitric
oxid
synthas
ino
express
inhibit
jakstat
signal
prevent
ifnmedi
transcript
activ
ata
also
previous
shown
increas
adenoviru
type
titer
cell
infect
activ
innat
immun
system
induc
intracellular
signal
pathway
lead
express
protein
proinflammatori
microbicid
activ
includ
cytokin
ifn
ifn
signal
one
import
cellular
defens
mechan
viral
clearanc
howev
vero
cell
dysfunct
intracellular
antivir
signal
pathway
vero
cell
inabl
produc
cell
produc
explain
permiss
natur
viral
product
ata
known
activ
rafmekmapk
pathway
insulinlik
growth
receptor
protein
kinas
c
signal
report
ata
survivalpromot
effect
transduct
via
activ
insulinlik
growth
receptor
signal
pathway
akt
map
mitogenactiv
protein
kinas
observ
ata
treatment
delay
plaqu
format
cell
lysi
cell
monolay
cpe
may
suggest
antiapoptot
properti
ata
also
shown
prevent
apoptot
cell
death
varieti
cell
type
includ
breast
cancer
cell
macrophag
raw
cell
rat
pheochromocytoma
cell
interestingli
ata
millimolar
higher
concentr
known
antivir
agent
vero
cell
figur
import
fetal
bovin
serum
fb
atahsv
protocol
follow
experi
conduct
determin
optim
condit
effect
presenc
absenc
fb
hsv
titer
ata
protocol
exampl
ata
fb
either
ad
omit
step
ata
ata
ad
without
presenc
fb
dnase
resist
particl
per
millilit
drpml
titer
vector
reduc
plaqueform
unit
per
millilit
pfuml
titer
detect
limit
titer
express
mean
valu
sd
drpml
shown
black
bar
mean
valu
sd
pfuml
shown
white
bar
result
repres
two
independ
experi
n
express
mean
sd
ata
aurintricarboxyl
acid
hsv
herp
simplex
viru
find
titer
actual
increas
ata
micromolar
concentr
howev
possibl
antivir
effect
observ
ata
ad
serumfre
media
ata
polycarboxyl
would
bind
electrostat
interact
protein
contain
posit
charg
residu
given
myriad
possibl
interact
site
consid
nonspecif
enzym
inhibitor
establish
exact
mechan
action
ata
yield
increas
therefor
would
simpli
remain
unknown
point
find
ata
increas
yield
import
implic
largescal
product
raav
vector
product
veroderiv
cell
hekderiv
cell
cell
obtain
appli
genet
technolog
corpor
alachua
fl
vero
cell
purchas
american
type
cultur
collect
manassa
va
cell
maintain
dulbecco
modifi
eagl
medium
dmem
contain
fb
hyclon
south
logan
ut
either
mgml
geneticin
invitrogen
life
technolog
grand
island
ny
cell
penicillinstreptomycin
corn
cellgro
mediatech
manassa
va
cell
ko
strain
deriv
ko
strain
vector
rhsvegfp
produc
cell
line
obtain
appli
genet
technolog
corpor
mcintyr
strain
purchas
advanc
biotechnolog
columbia
md
ata
experi
mmoll
stock
ata
sigmaaldrich
st
loui
mo
gener
mmoll
sodium
bicarbon
water
solut
dilut
dmem
fb
concentr
rang
ata
ataml
vector
rhsvegfp
strain
propag
cell
line
ko
strain
mcintyr
strain
propag
vero
cell
line
ata
appli
media
infect
ata
dilut
step
ata
figur
infect
multipl
infect
typic
cell
sixwel
plate
perform
vol
total
final
media
volum
hour
remain
media
total
final
volum
ad
dilut
step
cell
incub
hour
supernat
harvest
perform
assay
obtain
titer
drpml
pfuml
infecti
vector
particl
harvest
hour
postinfect
collect
cultur
supernat
titer
stock
drpml
determin
taqman
assay
viral
genom
within
crude
cultur
medium
quantifi
via
treatment
presenc
dnase
promega
madison
wi
u
ml
final
concentr
minut
follow
digest
proteinas
k
invitrogen
life
technolog
uml
final
concentr
minut
denatur
minut
linear
plasmid
pzero
obtain
appli
genet
technolog
corpor
use
gener
standard
curv
primerprob
set
specif
vector
genom
sequenc
f
r
probe
cgacgaagactccgacgccacctctamra
amplif
polymeras
chain
reaction
pcr
product
achiev
follow
cycl
paramet
cycl
minut
cycl
minut
cycl
second
cycl
second
result
express
mean
rhsv
drpml
titer
sd
statist
analyz
prism
graphpad
softwar
graphpad
softwar
la
jolla
ca
titer
stock
pfuml
also
determin
within
crude
cultur
medium
pfu
ml
quantifi
serial
dilut
dmem
fb
penicillin
streptomycin
treatment
either
cell
hour
posttreat
infecti
media
content
adjust
spike
appropri
wv
phosphatebuff
salin
solut
penstrep
hour
postinfect
media
remov
plate
dri
fix
cell
monolay
treat
hors
radish
peroxidaseconjug
antibodi
dako
carpinteria
ca
follow
vector
vip
peroxidas
substrat
kit
vector
lab
burlingam
ca
enumer
pfu
titer
calcul
result
express
mean
rhsv
pfuml
titer
sd
statist
analyz
prism
graphpad
softwar
raav
product
cell
cell
simultan
coinfect
rhsvegfp
vector
describ
kang
et
al
hour
postinfect
infecti
medium
exchang
dmem
fb
equival
doubl
preinfect
cultur
volum
time
harvest
cell
pellet
frozen
drp
titer
quantifi
realtim
pcr
block
appli
biosystem
fast
realtim
pcr
system
appli
biosystem
life
technolog
grand
island
ny
crude
sampl
subject
three
cycl
freez
thaw
incub
presenc
uml
benzonas
endonucleas
emd
millipor
billerica
mmoll
mgcl
final
concentr
protein
grade
tween
incub
minut
follow
gibco
trypsin
invitrogen
life
technolog
digest
minut
final
treatment
dnase
u
ml
final
concentr
minut
perform
denatur
minut
linear
plasmid
genzym
framingham
use
gener
standard
curv
primerprob
set
specif
simian
viru
poli
sequenc
raavf
raavr
raavprob
amplif
pcr
product
achiev
follow
cycl
paramet
cycl
minut
cycl
minut
cycl
second
cycl
second
result
express
mean
raav
drpml
titer
sd
statist
analyz
prism
graphpad
softwar
pp
ja
jk
hr
scw
employe
genzym
sanofi
compani
thank
jennif
tousign
valuabl
comment
manuscript
effect
aurintricarboxyl
acid
ata
residu
herp
simplex
stock
product
recombin
adenoassoci
viru
raav
virion
raavgfp
vector
produc
coinfect
rhsvegfp
vector
human
embryon
kidney
hek
cell
plate
ata
shown
slightli
increas
raav
yield
dnase
resist
particl
drp
per
cell
ata
spike
directli
cell
media
hour
hsv
coinfect
step
effect
observ
ata
concentr
cell
hour
hsv
coinfect
higher
result
repres
two
independ
experi
n
express
mean
sd
raav
drpcell
egfp
enhanc
gfp
gfp
green
fluoresc
protein
